Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma ; volume:14 ; number:1 ; day:13 ; month:12 ; year:2023 ; pages:1-15 ; date:12.2023
Nature Communications ; 14, Heft 1 (13.12.2023), 1-15, 12.2023
- Urheber
-
Nomura, Miyuki
Ohuchi, Mai
Sakamoto, Yoshimi
Kudo, Kei
Yaku, Keisuke
Soga, Tomoyoshi
Sugiura, Yuki
Morita, Mami
Hayashi, Kayoko
Miyahara, Shuko
Sato, Taku
Yamashita, Yoji
Ito, Shigemi
Kikuchi, Naohiko
Sato, Ikuro
Saito, Rintaro
Yaegashi, Nobuo
Fukuhara, Tatsuro
Yamada, Hidekazu
Shima, Hiroshi
Nakayama, Keiichi I.
Hirao, Atsushi
Kawasaki, Kenta
Arai, Yoichi
Akamatsu, Shusuke
Tanuma, Sei-ichi
Sato, Toshiro
Nakagawa, Takashi
Tanuma, Nobuhiro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-43630-3
- URN
-
urn:nbn:de:101:1-2024022308075279404678
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nomura, Miyuki
- Ohuchi, Mai
- Sakamoto, Yoshimi
- Kudo, Kei
- Yaku, Keisuke
- Soga, Tomoyoshi
- Sugiura, Yuki
- Morita, Mami
- Hayashi, Kayoko
- Miyahara, Shuko
- Sato, Taku
- Yamashita, Yoji
- Ito, Shigemi
- Kikuchi, Naohiko
- Sato, Ikuro
- Saito, Rintaro
- Yaegashi, Nobuo
- Fukuhara, Tatsuro
- Yamada, Hidekazu
- Shima, Hiroshi
- Nakayama, Keiichi I.
- Hirao, Atsushi
- Kawasaki, Kenta
- Arai, Yoichi
- Akamatsu, Shusuke
- Tanuma, Sei-ichi
- Sato, Toshiro
- Nakagawa, Takashi
- Tanuma, Nobuhiro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
Author Correction: Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
Synthetic lethal treatment strategies for tumor cell senescence
Epigenetic based synthetic lethal strategies in human cancers
A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers
RNA interference screens discover proteases as synthetic lethal partners of PI3K inhibition in breast cancer cells
A synthetic lethal strategy to target chromosome 8p deleted cancers
Rapid-SL identifies synthetic lethal sets with an arbitrary cardinality
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors
Target expression is a relevant factor in synthetic lethal screens
Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
Author Correction: Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
Synthetic lethal treatment strategies for tumor cell senescence
Epigenetic based synthetic lethal strategies in human cancers
A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers
RNA interference screens discover proteases as synthetic lethal partners of PI3K inhibition in breast cancer cells
A synthetic lethal strategy to target chromosome 8p deleted cancers
Rapid-SL identifies synthetic lethal sets with an arbitrary cardinality
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors
Target expression is a relevant factor in synthetic lethal screens
Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
Author Correction: Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
Synthetic lethal treatment strategies for tumor cell senescence
Epigenetic based synthetic lethal strategies in human cancers
A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers
RNA interference screens discover proteases as synthetic lethal partners of PI3K inhibition in breast cancer cells
A synthetic lethal strategy to target chromosome 8p deleted cancers
Rapid-SL identifies synthetic lethal sets with an arbitrary cardinality
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors